Corvus Pharmaceuticals CRVS Q1 2026 Earnings RD Pipeline Progress Amid Slight EPS Miss HSLV Q1 2026 Earnings Silver Explorer Reports Stunning EPS Surprise Despite Absence of Revenue ARDT Q1 2026 Earnings EPS Surges Past Estimates with 486 Beat SOHOB Q2 2025 Earnings Preferred Stock Holds Steady as Company Reports Positive EPS Despite Lack of Estimates MMSI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response LBRDA Q3 2025 Earnings EPS Surges Past Estimates Despite Broadband Headwinds